The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival

T-cell acute lymphoblastic leukemia (T-ALL) is a cancer of the immune system. Approximately 20% of paediatric and 50% of adult T-ALL patients have refractory disease or relapse and die from the disease. To improve patient outcome new therapeutics are needed. With the aim to identify new therapeutic...

Повний опис

Бібліографічні деталі

Автори:	Vesna S. Stanulović, Shorog Al Omair, Michelle A.C. Reed, Jennie Roberts, Sandeep Potluri, Taylor Fulton-Ward, Nancy Gudgeon, Emma L. Bishop, Juliette Roels, Tracey A. Perry, Sovan Sarkar, Guy Pratt, Tom Taghon, Sarah Dimeloe, Ulrich L. Günther, Christian Ludwig, Maarten Hoogenkamp
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Ferrata Storti Foundation 2024-05-01
Серія:	Haematologica
Онлайн доступ:	https://haematologica.org/article/view/11616
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!